Dear Patient Advocacy Organizations, Neurogene Inc., a biotech company committed to developing life-changing genetic medicines for patients and their families affected by rare neurological disorders, is excited to share an important update on our development program for CLN5, a subtype of Neuronal Ceroid Lipofuscinosis (NCL), […]